# Amwise Diagnostics Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amwise-diagnostics-pte

- Industry: Biotechnology
- Headquarters: Taipei, Taiwan - China
- Website: www.amwisediagnostics.com
- Latest round: Series A (Jan 1, 2016)
- Investors on record: 3

## About

Established in 2015 and based in Taipei, China, Amwise Diagnostics Pte. Ltd. operates as a biotechnology company dedicated to providing cancer treatment solutions for patients. In February 2020, the company raised USD 10 million in series B funding led by new investor Simcere Pharmaceutical Group.

The company mainly provides breast cancer consultation and treatment options. It uses breast cancer diagnosis and gene testing technology to provide a personalized breast cancer recurrence risk analysis report. The product is suitable for patients with stage I or stage II breast cancer (early breast cancer).

The company generates revenue by providing breast cancer consultation and treatment options.

## Funding rounds

- Series A, Jan 1, 2016 — WI Harper Group, Lippo Group, Alibaba Entrepreneurs Fund

## Investors

- WI Harper Group (https://capitalatlas.ai/funds/wi-harper-group) — Series A
- Lippo Group — Series A
- Alibaba Entrepreneurs Fund (https://capitalatlas.ai/funds/alibaba-entrepreneurs-fund) — Series A